The Role of COX-2 Inhibitors on Experimental Colitis

QR Code

The Role of COX-2 Inhibitors on Experimental Colitis

None

Saved in:

Bibliographic Details
Main Authors:	Paiotti, Ana Paula R., Artigiani-Neto, Ricardo, Ribeiro, Daniel A., Miszputen, Sender J., Franco, Marcello
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/26838
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CARDIOVASCULAR EFFECTS OF SELECTIVE COX-2 INHIBITORS IN RHEUMATIC DISEASES
by: Rimma Mikhailovna Balabanova
Published: (2010-06-01)

CELEBREX: THE FIRST SPECIFIC INHIBITOR OF COX-2: NEW DATA
by: E L Nassonov
Published: (2000-08-01)

MELOXICAM (MOVAL1S): THE SELECTIVE INHIBITOR OF COX-2 IN CLINICAL PRACTICE
by: V A Nassonova
Published: (2000-08-01)

Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin
by: Muhammad Suleman, et al.
Published: (2025-07-01)

Alfalfa Flavonoids Mitigate Salmonella‐Induced Colitis via the Keap1‐Nrf2 and TLR4/NF‐κB/COX‐2 Pathways
by: Xiaoli Qin, et al.
Published: (2025-07-01)

Role of COX-2 in the regulation of the metastatic potential of human breast tumor cells
by: M. A. Taipov, et al.
Published: (2014-07-01)

Computational identification of dual COX-1 and NIK inhibitors from marine microalga Chlorella vulgaris
by: Mahesh Samantaray, et al.
Published: (2025-09-01)

Acetyl Salicylic Acid, COX‐2 Inhibitors and Other NSAIDs and Breast Cancer Survival in a Finnish Population‐Based Cohort
by: M. Malin, et al.
Published: (2025-07-01)

A Delayed Presentation of Immune Checkpoint Inhibitor Colitis
by: Alicia Nahhas, et al.
Published: (2025-06-01)

Australian architects--Philip Cox
Published: (1984)

Survival analysis of Kasturi tobacco plants in Jember district using the stratified cox and extended cox models.
by: Angga Iryanto Pratama, et al.
Published: (2025-06-01)

Results of the microbiota assessment in experimental ulcerative colitis
by: A. D. Kim, et al.
Published: (2021-04-01)

Evaluating the Anti-inflammatory Efficacy of Steroids, COX-2 Selective, and Nonselective NSAIDs in Contusion Spinal Cord Injury: An Experimental Analysis
by: Sreelakshmi Kokkatt Balachandran, et al.
Published: (2025-06-01)

Interaction Phloroglucinol as inflammation therapy through Cyclooxygenase-2 (COX-2) gene inhibition
by: Yohanes Bare
Published: (2022-03-01)

Modification and Characterization of Some New Levofloxacin Heterocyclic Derivatives as COX-2 Enzyme Inhibitors and Evaluate Their Efficacy Pharmacokinetics by Molecular Docking and the Swiss ADME Studies
by: Mustafa Moaied Rabeaa, et al.
Published: (2024-04-01)

Tumour-Associated Macrophages (TAMs) and Cox-2 Expression in Canine Melanocytic Lesions
by: Pires, Isabel, et al.
Published: (2011)

Melanoma-Induced Endothelial Cell Growth Involves Phospholipase A2 and COX2 Upregulation
by: Alberghina, Mario, et al.
Published: (2011)

Expression of cyclooxygenase-2 (COX-2) in colorectal adenoma in an indigenous African population in northern Nigeria
by: Abdulrazaq A. Jimoh, et al.
Published: (2025-07-01)

ATM transaction simulation: combination of ACDs and cox process
by: Reza Habibi
Published: (2025-06-01)

Features of using Cox regression in various instrumental environments
by: I. V. Kramarenko, et al.
Published: (2022-11-01)

Carcinogenesis in Ulcerative Colitis
by: Humphries, Adam, et al.
Published: (2012)

Licochalcone D mitigates intracerebral hemorrhage-induced ferroptosis of neurons through COX2 inhibition
by: JiaLi Song, et al.
Published: (2025-07-01)

Ulcerative Colitis in Children and Adolescents
by: Day, Andrew S., et al.
Published: (2011)

Effect of local ozone therapy on inflammatory markers in experimental ulcerative colitis
by: E. V. Davydova, et al.
Published: (2022-04-01)

Cox proportion hazard model for patients with hepatitis disease in Iraq
by: Baghdad Science Journal
Published: (2009-09-01)

Integrated Cox’s model for predicting survival time of glioblastoma multiforme
by: Zhibing Ai, et al.
Published: (2017-04-01)

Understanding Vulnerability to Natural Hazards of Displaced Persons in Cox’s Bazar
by: Jack Dano, et al.
Published: (2025-07-01)

TNF-α Inhibitor-Induced Psoriasis and Psoriatic Alopecia in Adolescent with Ulcerative Colitis: Clinical Case
by: Eduard T. Ambarchyan, et al.
Published: (2023-11-01)

MicroRNA-16 suppresses glioblastoma proliferation and invasion by targeting COX2: Implications for therapeutic strategies
by: Xiaodong Zou, et al.
Published: (2025-08-01)

Investigating the cardiorespiratory fitness gene COX7A2L in cardiomyocytes: Viability and mitochondrial function.
by: Ada Nilsen Nordeidet, et al.
Published: (2025-01-01)

Global deletion of COX-2 attenuates hepatic inflammation but impairs metabolic homeostasis in diet-induced obesity
by: Jeyakumar Balakrishnan, et al.
Published: (2025-06-01)

Clinical and Morphological Analysis of Efficacy of Intraperitoneal Ozone Application in Experimental Colitis: Preclinical Randomized Experimental Study
by: M. V. Osikov, et al.
Published: (2023-02-01)

Amebic Colitis
by: Isea, María Carolina, et al.
Published: (2012)

Ulcerative Colitis
by: Ajlouni, Yousef, et al.
Published: (2012)

Ulcerative Colitis
by: Ahmed, Iftikhar, et al.
Published: (2011)

Colitis microscópica
by: Jorge Luís Bauta Desdín, et al.
Published: (2017-05-01)

Antiulcerative and antioxidant action of hydroalcoholic extract of Anacardium occidentale L. leaves in an induced experimental colitis model
by: Victor Pedro, et al.
Published: (2025-07-01)

Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms
by: Shuzhen Mao, et al.
Published: (2025-07-01)

Risk modeling for esophageal cancer based on adaptive Lasso and Cox regression
by: Xiaoli Li, et al.
Published: (2025-08-01)

Targeting Biomarkers of Proliferation and Inflammation (Ki67, p53, and COX-2) in Actinic Keratoses with Photodynamic Therapy
by: Justyna Ceryn, et al.
Published: (2025-06-01)